Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial
Jason S. Richardson, Deborah M. Anderson, Jason Mendy, Lauren C. Tindale, Sufia Muhammad, Tobi Loreth, Sarah Royalty Tredo, Kelly L. Warfield, Roshan Ramanathan, Jorge Caso, Victoria A. Jenkins, Patrick Ajiboye, Lisa Bedell
Topics & Concepts
ImmunogenicityPlaceboMedicineVirusVirologyVirus-like particleChikungunyaDouble blindSafety profileChikungunya feverImmunologyInternal medicineAdverse effectBiologyAlternative medicineAntibodyRecombinant DNAPathologyGeneBiochemistryMosquito-borne diseases and controlVirology and Viral DiseasesViral Infections and Outbreaks Research